KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 159 filers reported holding KITE PHARMA INC in Q2 2015. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $44,612,000 | -64.8% | 248,104 | -79.7% | 1.81% | -69.4% |
| Q2 2017 | $126,882,000 | +12.7% | 1,223,899 | -14.6% | 5.91% | +3.6% |
| Q1 2017 | $112,547,000 | +99.4% | 1,433,899 | +13.9% | 5.71% | +97.0% |
| Q4 2016 | $56,449,000 | +0.2% | 1,258,899 | +24.8% | 2.90% | -6.6% |
| Q3 2016 | $56,357,000 | +64.6% | 1,008,899 | +47.3% | 3.10% | +60.2% |
| Q2 2016 | $34,245,000 | +50.7% | 684,899 | +38.4% | 1.94% | +42.3% |
| Q1 2016 | $22,725,000 | -7.8% | 494,988 | +23.8% | 1.36% | -13.4% |
| Q4 2015 | $24,648,000 | +8.0% | 399,988 | -2.4% | 1.57% | -7.8% |
| Q3 2015 | $22,828,000 | -24.8% | 410,002 | -17.7% | 1.70% | -26.2% |
| Q2 2015 | $30,366,000 | +96.0% | 498,060 | +85.5% | 2.31% | +84.3% |
| Q1 2015 | $15,489,000 | – | 268,530 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $135,991,000 | 55.96% |
| Lamond Capital Partners LLC | 365,900 | $21,101,000 | 13.82% |
| EcoR1 Capital, LLC | 438,400 | $25,283,000 | 12.80% |
| DSAM Partners (London) Ltd | 399,571 | $23,043,000 | 6.08% |
| Silver Rock Financial LLC | 476,563 | $27,483,000 | 5.08% |
| Cormorant Asset Management, LP | 255,000 | $14,706,000 | 2.27% |
| Opaleye Management Inc. | 76,000 | $4,383,000 | 2.22% |
| Ghost Tree Capital, LLC | 60,000 | $3,460,000 | 1.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 110,970 | $6,400,000 | 1.09% |
| PURA VIDA INVESTMENTS, LLC | 44,250 | $2,552,000 | 0.94% |